Fox Mark
Digestive Function: Basel, Laboratory and Clinic for Motility Disorders and Functional Digestive Diseases, Centre for Integrative Gastroenterology, Klinik Arlesheim, Arlesheim, Switzerland.
Department of Gastroenterology and Hepatology, University Zürich, Zurich, Switzerland.
Visc Med. 2024 Dec;40(6):299-309. doi: 10.1159/000541358. Epub 2024 Oct 18.
Gastro-oesophageal reflux disease (GORD) is extremely common, with at least 1 in 10 people in the general population reporting heartburn and acid regurgitation on a weekly basis. GORD can also be associated with a variety of atypical symptoms, including chest pain, chronic cough, and laryngopharyngeal symptoms. The causes of GORD are multifactorial, and the severity of symptoms is influenced by peripheral and central factors, including psychosocial stress and anxiety. Therefore, for a variety of reasons, no single investigation provides a definitive diagnosis, and standard treatment with acid suppressants is not always effective.
This review introduces the Lyon Consensus, now in its second iteration, a classification system that provides a "conclusive" positive or negative diagnosis of GORD by integrating the results of endoscopy, ambulatory reflux monitoring, and high-resolution manometry. Different algorithms are applied to patients with high and low pre-test probability of a causal relationship between reflux episodes and patient symptoms. The results of these studies identify patients with "actionable" results that require escalation, revision, or discontinuation of GORD treatment. Guidance is provided on the range of conservative treatments available for GORD, including dietary and lifestyle advice, antacids and alginates, and drugs that suppress acid secretion.
GORD is a common disorder; however, the causes of reflux and symptoms can be complex. As a result, the diagnosis can be missed, and management is sometimes challenging, especially for patients with atypical symptoms. The Lyon classification establishes a conclusive diagnosis of GORD, based on results of endoscopic and physiological investigation. Typical symptoms usually respond to empiric use of alginate-antacid preparations and acid suppression; however, the management of treatment refractory symptoms is tailored to the individual.
胃食管反流病(GORD)极为常见,普通人群中至少每10人就有1人每周出现烧心和反酸症状。GORD还可能伴有多种非典型症状,包括胸痛、慢性咳嗽和咽喉部症状。GORD的病因是多因素的,症状的严重程度受外周和中枢因素影响,包括心理社会压力和焦虑。因此,由于多种原因,没有单一的检查能提供明确诊断,使用抑酸剂的标准治疗也并非总是有效。
本综述介绍了现已进行第二次修订的里昂共识,这是一种通过整合内镜检查、动态反流监测和高分辨率测压结果来对GORD作出“确定性”阳性或阴性诊断的分类系统。针对反流发作与患者症状之间因果关系的预测试概率高和低的患者应用不同算法。这些研究结果可识别出需要升级、修订或停用GORD治疗的具有“可采取行动”结果的患者。文中还提供了针对GORD的一系列保守治疗方法的指导,包括饮食和生活方式建议、抗酸剂和藻酸盐,以及抑制胃酸分泌的药物。
GORD是一种常见疾病;然而,反流和症状的病因可能很复杂。因此,诊断可能会被遗漏,管理有时也具有挑战性,尤其是对于有非典型症状的患者。里昂分类基于内镜和生理检查结果对GORD作出确定性诊断。典型症状通常对经验性使用藻酸盐抗酸制剂和抑酸治疗有反应;然而,对治疗难治性症状的管理需因人而异。